When a person’s asthma is severe or isn’t managed well by typical protocols, they may be a good candidate for pulmonary ...

Poor treatment of asthma and COPD puts a huge burden on the NHS. For example, £1 billion is spent on asthma treatment in the UK each year and represents 60,000 to 65,000 hospital admissions. In ...

The Dry Powder Inhaler Market is poised for significant ... by rising prevalence of respiratory diseases such as asthma and COPD, combined with technological advancements in drug delivery systems.

In patients with chronic obstructive pulmonary disease (COPD), the first year of using single-inhaler triple therapy is associated with slightly more major adverse cardiovascular events (MACE) than ...

I was diagnosed with COPD last year after struggling with multiple symptoms. I quit smoking over 10 years ago, but I'm dealing with the effects of it ...

Fluticasone is a prescription corticosteroid for long-term treatment of respiratory disorders, such as asthma and COPD. It is not supposed to relieve sudden breathing problems, so it won’t replace a ...

Afrezza, world’s only rapid-acting, inhaled insulin for type 1 & type 2 diabetes patients & manufactured by MannKind, ...

The role of combination therapy is explored for the treatment of COPD. December 14th 2022EP. 5: Implementing Inhaled Corticosteroids (ICS) into COPD Patient Treatment Regimen Inhaled ...

reduce symptoms and improve the overall quality of life for COPD patients, which typically runs for six to 12 weeks and ...

Objective: To review the basis for the estimated comparative daily dosages of inhaled corticosteroids for children and adults that are presented in the National Heart, Lung, and Blood Institute's ...

A breast cancer drug - which keeps the disease stable for up to four times longer than the previous treatment - will be ...